Navigation Links
Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center
Date:3/5/2009

First and only specialized clinic furthers AED industry-leading commitment to research and development

Grand opening in conjunction with the 67th annual meeting of the American Academy of Dermatology (AAD)

HAYWARD, Calif., March 5 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM) today announced the opening of the Solta Medical Aesthetic Center to advance the company's new product development, facilitate research on the innovative Thermage(R) and Fraxel(R) product lines and serve as a destination where physicians can participate in research studies and training. Solta is the first company in the aesthetic energy device (AED) space with an in-house clinic and biomedical engineering lab.

"The Solta Medical Aesthetic Center supports our pursuit of excellence in branded aesthetic treatments, enhances our ability to quickly bring new products to market and ensures the quality of anti-aging solutions we offer to patients and physicians," said Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical, Inc. "We invite physicians to visit our Aesthetic Center and see firsthand why Thermage and Fraxel systems are leading the way in terms of clinical outcomes, patient satisfaction and return on our customers' investment."

Currently, there are more than 4,500 physicians in nearly 80 countries who perform Thermage and Fraxel treatments. The Aesthetic Center serves as a central research destination for physicians around the world to access the latest findings about Thermage and Fraxel treatments.

"The Solta Medical Aesthetic Center allows for a seamless transition from the research bench to the treatment room," said Vic A. Narurkar, M.D., dermatologist and founder of the Bay Area Laser Institute in San Francisco, California. "Solta's state-of-the-art cl
'/>"/>

SOURCE Solta Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Solta Medical Reports Fourth Quarter and Full Year 2008 Results
2. Solta Medical, Inc. Announces Preliminary Financial Results for the Fourth Quarter of 2008
3. Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments
4. Thermage, Inc. Announces Name Change to Solta Medical, Inc.
5. China Sky One Medical, Inc. Exports Sumei Slim Patch to South Korea and Sudan
6. China Sky One Medical, Inc. Reaffirms Guidance for 2008 Revenue and Net Income and Provides Business Update
7. Nonin Medical, Inc. Makes History With the First Continua(TM) Certified Product
8. Insightra Medical, Inc. Gains FDA clearance for the Most Complete Range of 7Fr Intra Aortic Balloon (IAB) Catheters
9. China Sky One Medical, Inc. Provides Business Update
10. China Sky One Medical, Inc. Obtains Production Rights for Two Additional Drugs
11. "The Economic Report" Show to Feature Gradient Medical, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Dec. 14 Tough Enough To Wear Pink(TM) ... cancer, celebrated its fifth anniversary at the signature ... Wrangler National Finals Rodeo (Wrangler NFR) in Las ... rough-and-tumble rodeo cowboys, the support of the western ... sold-out crowd sported pink shirts, hats, bracelets and ...
(Date:12/14/2009)... higher than generally thought, raising concerns about increased risk for cancer, ... San Francisco (UCSF) imaging specialists. , ... San ... CT procedures vary widely and are higher than generally thought, raising ... led by University of California, San Francisco (UCSF) imaging ...
(Date:12/14/2009)... Federation of America (HFA) expresses its concern regarding ... 929 and the American Red Cross of Pennsylvania ... skilled workers to provide clean, safe blood to ... as clotting factor for use in treating hemophilia ... of Blood Services at the American Red Cross ...
(Date:12/14/2009)... the bump in odds is small and shouldn,t worry ... News) -- Older women who take antidepressants may have ... and death compared to women not on the medications, ... be different from clinical significance," stressed Dr. Jordan W. ... School, and lead author of a report in the ...
(Date:12/14/2009)... might lead to better treatments for asthma, COPD, researchers ... have identified five genetic variants that influence lung function, ... for lung diseases. , The international team of researchers ... the 2.5 million sites across the human genome in ... the team to the five common genetic variants associated ...
Breaking Medicine News(10 mins):Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 2Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 3Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 5Health News:HFA Voices Blood Safety Concerns 2Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3
... DRAXIS Health Inc, (TSX:,DAX) (NASDAQ: DRAX ) has applied ... Issuer Bid (NCIB), subject to TSX approval, to buy back ... maximum number of common shares which may be purchased for,cancellation ... which,represents 10% of the common shares in the public float ...
... G. Komen for the Cure, Participates in Nationwide Campaign Challenging U.S. to ... ... Jan. 11, elected officials,will join advocates from the San Francisco Bay Area ... pink, highlighting the urgent need,to address disparities in breast cancer early detection ...
... Alarming New HIV Rates; Governor Should Cut,Bureaucracy, Corporate ... Healthcare,Foundation (AHF) today urged California Governor Arnold Schwarzenegger ... cuts in AIDS services,that will reduce and threaten ... HIV/AIDS as he seeks to close a $14 ...
... 10 The U.K. is currently dealing,with an outbreak ... infect,hundreds of thousands of people in the coming weeks. ... the U.K.,s Health Protection Agency,(HPA), says doctors and hospitals ... People suffering from the virus are being asked to ...
... blood cell numbers , A common treatment ... (rbcs) caused by their insufficient production, excessive destruction, or ... a hormone that stimulates the production of rbc precursors ... do not respond to treatment with Epo. However, a ...
... study shows preconditioning cardiac cells helps organ better tolerate loss ... Just as daily runs can prepare you to survive a ... could condition cardiac cells to better withstand the damage of ... of Cincinnati suggests. , Ultimately, if validated in humans, these ...
Other Medicine News:Health News:DRAXIS Announces Application for Normal Course Issuer Bid 2Health News:DRAXIS Announces Application for Normal Course Issuer Bid 3Health News:DRAXIS Announces Application for Normal Course Issuer Bid 4Health News:San Francisco City Hall Turns Pink, Draws Attention to Disparities in Breast Cancer Screening, Treatment 2Health News:AHF to Schwarzenegger: 'AIDS Cuts Are Deadly' 2Health News:AHF to Schwarzenegger: 'AIDS Cuts Are Deadly' 3Health News:CeraLyte ORS to Prevent Dehydration from Norovirus Outbreak 2Health News:JCI online early table of contents: Jan. 10 2008 2Health News:JCI online early table of contents: Jan. 10 2008 3Health News:JCI online early table of contents: Jan. 10 2008 4Health News:JCI online early table of contents: Jan. 10 2008 5Health News:JCI online early table of contents: Jan. 10 2008 6Health News:JCI online early table of contents: Jan. 10 2008 7Health News:JCI online early table of contents: Jan. 10 2008 8Health News:JCI online early table of contents: Jan. 10 2008 9Health News:JCI online early table of contents: Jan. 10 2008 10Health News:JCI online early table of contents: Jan. 10 2008 11Health News:Priming Heart Before an Attack Could Limit Damage 2Health News:Priming Heart Before an Attack Could Limit Damage 3
(Date:12/14/2009)... we have been tracking Tianyin Pharmaceuticals (NYSE Amex: ... up had been with the potential dilution from "in-the-money" ... guidance of $11.3 million represents a 43.0% increase from ... the increase in shares poses some uncertainty regarding the ... share price and the Treasury method of accounting for ...
(Date:12/14/2009)... -- According to Millennium Research Group (MRG), the ... use of safety devices for small-bore connectors for ... driver of the enteral feeding device markets in ... US and European Markets for Enteral Feeding Devices ... segment will experience the greatest impact from facilities ...
(Date:12/14/2009)... Manchester Pharmaceuticals, Inc.(TM) announced today the ... On October 22, 2009, the US Food and ... for patients suffering from gallstones in whom surgery ... or advanced age. ,, Chenodal prescriptions have started ... Health Resources ("Centric"), a specialty pharmacy company. ...
Breaking Medicine Technology:GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3Manchester Announces Availability of Chenodal(TM) 2GenVaults GenSolve 28TM 29 Reagents Enable State of the Art Genomic Analysis of Dried Blood Spots 53720 1GenVaults GenSolve 28TM 29 Reagents Enable State of the Art Genomic Analysis of Dried Blood Spots 53720 2GenVaults GenSolve 28TM 29 Reagents Enable State of the Art Genomic Analysis of Dried Blood Spots 53720 3Effient 28TM 29 is Now Available in Pharmacies 53716 1Effient 28TM 29 is Now Available in Pharmacies 53716 2Effient 28TM 29 is Now Available in Pharmacies 53716 3Effient 28TM 29 is Now Available in Pharmacies 53716 4BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 1BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 3
... the majority of acute lymphoblastic leukemia relapse cases arise from ... , MEMPHIS, Tenn., Nov. 27 ... distinctive genetic changes in the cancer cells of children with ... a pathway to designing treatments for ALL relapse in children ...
... and University of Louisville hand surgeons performed ... resident, Jan "Erik" Hondusky, at Louisville,s Jewish Hospital Hand ... procedure began around noon and was completed shortly after ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20081125/DC48555-a ...
Other Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3
Alexander periosteal elevators....
Lambotte periosteal elevators....
Cottle periosteal & skin elevator, 7 1/2", slightly curved blade, 9 mm wide....
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Medicine Products: